Form 8-K - Current report:
SEC Accession No. 0001213900-25-053367
Filing Date
2025-06-11
Accepted
2025-06-11 13:00:22
Documents
15
Period of Report
2025-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245387-8k_onconetix.htm   iXBRL 8-K 34203
2 FORM OF CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCO ea024538701ex3-1_onconetix.htm EX-3.1 6818
3 NOTE, DATED JUNE 5, 2025 ea024538701ex10-1_onconetix.htm EX-10.1 28753
4 PRESS RELEASE, DATED JUNE 11, 2025 ea024538701ex99-1_onconetix.htm EX-99.1 13701
  Complete submission text file 0001213900-25-053367.txt   271848

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE onco-20250611.xsd EX-101.SCH 3041
6 XBRL LABEL FILE onco-20250611_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE onco-20250611_pre.xml EX-101.PRE 22376
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0245387-8k_onconetix_htm.xml XML 3798
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 251039488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)